Vascular disease in cocaine addiction
- PMID: 28363516
- PMCID: PMC5757372
- DOI: 10.1016/j.atherosclerosis.2017.03.019
Vascular disease in cocaine addiction
Abstract
Cocaine, a powerful vasoconstrictor, induces immune responses including cytokine elevations. Chronic cocaine use is associated with functional brain impairments potentially mediated by vascular pathology. Although the Crack-Cocaine epidemic has declined, its vascular consequences are increasingly becoming evident among individuals with cocaine use disorder of that period, now aging. Paradoxically, during the period when prevention efforts could make a difference, this population receives psychosocial treatment at best. We review major postmortem and in vitro studies documenting cocaine-induced vascular toxicity. PubMed and Academic Search Complete were used with relevant terms. Findings consist of the major mechanisms of cocaine-induced vasoconstriction, endothelial dysfunction, and accelerated atherosclerosis, emphasizing acute, chronic, and secondary effects of cocaine. The etiology underlying cocaine's acute and chronic vascular effects is multifactorial, spanning hypertension, impaired homeostasis and platelet function, thrombosis, thromboembolism, and alterations in blood flow. Early detection of vascular disease in cocaine addiction by multimodality imaging is discussed. Treatment may be similar to indications in patients with traditional risk-factors, with few exceptions such as enhanced supportive care and use of benzodiazepines and phentolamine for sedation, and avoiding β-blockers. Given the vascular toxicity cocaine induces, further compounded by smoking and alcohol comorbidity, and interacting with aging of the crack generation, there is a public health imperative to identify pre-symptomatic markers of vascular impairments in cocaine addiction and employ preventive treatment to reduce silent disease progression.
Keywords: Atherosclerosis; Cardiotoxicity; Cocaine; Endothelial dysfunction; Neurotoxicity; Vascular disease.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Figures
Comment in
-
β-blocker treatment of vascular disease in cocaine addiction.Atherosclerosis. 2017 Sep;264:122. doi: 10.1016/j.atherosclerosis.2017.06.027. Epub 2017 Jun 15. Atherosclerosis. 2017. PMID: 28633764 No abstract available.
-
Reply to: "β-blocker treatment of vascular disease in cocaine addiction".Atherosclerosis. 2017 Sep;264:123-124. doi: 10.1016/j.atherosclerosis.2017.07.012. Epub 2017 Jul 15. Atherosclerosis. 2017. PMID: 28735812 Free PMC article. No abstract available.
References
-
- Substance Abuse and Mental Health Services Administration. NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. Substance Abuse and Mental Health Services Administration; Rockville, MD: 2014. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings.
-
- Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am. J. Cardiol. 2007;100:1040–1043. http://dx.doi.org/10.1016/j.amjcard.2007.04.049. - DOI - PubMed
-
- Radunski UK, et al. Increased extracellular volume in asymptomatic cocaine abusers detected by cardiovascular magnetic resonance imaging. J. Cardiovasc. Magn. Reson. (BioMed Central) 2013;15:1–2. http://dx.doi.org/10.1186/1532-429X-15-S1-E101. - DOI
-
- Darke S, Kaye S, Duflou J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes. Addict. (Abingd. Engl.) 2006;101:1771–1777. http://dx.doi.org/10.1111/j.1360-0443.2006.01601.x. - DOI - PubMed
-
- Ren H, et al. Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol. Psychiatry. 2012;17:1017–1025. http://dx.doi.org/10.1038/mp.2011.160. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
